Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 8, Number 2—February 2002

Synopsis

Current Status of Antimicrobial Resistance in Taiwan

Po-Ren Hsueh*, Cheng-Yi Liu†, and Kwen-Tay Luh*Comments to Author 
Author affiliations: *National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan; †Taipei Veterans General Hospital and National Yang-Ming University, Taipei, Taiwan

Main Article

Table 2

Prevalence of antimicrobial resistance in selected bacteria (all clinical isolates) isolated from 12 major hospitals, including National Taiwan University Hospital (NTUH), in Taiwan in 2000 and in all clinical isolates and isolates causing nosocomial infections from NTUH in 2000a

Resistant pathogen % of isolates
2,000 (12 hospitals) (clinical) 2,000 (NTUH) (clinical/nosocomial)
Methicillin-resistant Staphylococcus aureus 53-83 65/74
Erythromycin-resistant beta-hemolytic streptococci 30-51 34/-
Penicillin-nonsusceptible Streptococcus pneumoniae 60-84 77/-
Erythromycin-resistant S. pneumoniae 67-100 89/-
Gentamicin-resistant (high-level) enterococci 36-54 48/54
Vancomycin-resistant enterococci 1-3 3/2
Ampicillin-resistant H. influenzae 45-73 61/-
Cefotaxime-resistant Escherichia coli 5-19 12/19
Ciprofloxacin-resistant E. coli 11-33 20/29
Cefotaxime-resistant Klebsiella pneumoniae 4-34  9/18
Ciprofloxacin-resistant K. pneumoniae 5-33 9/16
Cefotaxime-resistant E. cloacae 36-68 45/49
Ampicillin-resistant non-typhoid Salmonella 44-69 56/-
Cefotaxime-resistant non- typhoid Salmonella 1-4 2/-
Quinolone resistant non-typhi Salmonella 0-16 0/-
Ceftazidime-resistant Pseudomonas aeruginosa 4-21 13/10
Imipenem-resistant P. aeruginosa 3-16 14/10
Ciprofloxacin-resistant P. aeruginosa 10-36 15/10
Imipenem-resistant Acinetobacter baumannii 0-19 19/16
Ciprofloxacin-resistant A. baumannii 54-74 54/42

aSusceptibility of these bacteria was determined by the standard disk-diffusion method.   

Main Article

TOP